DR PARUL GANJU

Ahammune Biosciences, Veeda Clinical Research announces start of human trials for new vitiligo drug

The preliminary research for AB1001 demonstrates that this drug candidate is both safe and efficacious for vitiligo treatment. The preclinical studies establish that the molecules have the potential to stop disease progression and also support repigmentation